Literature DB >> 1875971

Allergic rhinitis.

R M Naclerio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1875971     DOI： 10.1056/NEJM199109193251206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Economic outcomes for the treatment of allergic rhinitis.

Authors:  C M Kozma; M K Sadik; M L Watrous
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

2.  Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production.

Authors:  H M Dintzis; R Z Dintzis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

3.  Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries.

Authors:  C G Pinto; A Lafuma; F Fagnani; M J Nuijten; G Berdeaux
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  Current diagnosis and management of sinusitis.

Authors:  L R Willett; J L Carson; J W Williams
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

Review 5.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  Antileukotrienes in upper airway inflammatory diseases.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Kagan Ipci; Ethem Şahin
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

7.  Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.

Authors:  Eri Yasuoka; Kazuo Oshima; Katsuto Tamai; Takeshi Kubo; Yasufumi Kaneda
Journal:  J Mol Med (Berl)       Date:  2006-10-28       Impact factor: 4.599

Review 8.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Protective effects of deflazacort on allergen-specific conjunctival challenge.

Authors:  G Ciprandi; S Buscaglia; A Iudice; G P Pesce; M Bagnasco; G W Canonica
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

Authors:  K Masuyama; M R Jacobson; S Rak; Q Meng; R M Sudderick; A B Kay; O Lowhagen; Q Hamid; S R Durham
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.